Sanofi Nabs Priority Review For New Pompe Drug

And Rilzabritib Gets US Fast Track For ITP

 
• By Kevin Grogan
  
sanofi fast track
Avalglucosidase alfa and rilzabrutinib on track • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Scrip